CareDx
CDNA
184 hedge funds and large institutions have $1.23B invested in CareDx in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 49 reducing their positions, and 50 closing their positions.
61% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 49
1.89% more ownership
Funds ownership: 106.42% → 108.32% (+1.9%)
14% less funds holding
Funds holding: 213 → 184 (-29)
17% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $1.37M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less capital invested
Capital invested by funds: $2.02B → $1.23B (-$792M)
48% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 50
Top Buyers
Top Sellers
CDNA Hedge Fund Activity: Q2 2022 in Review
184 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q2 2022, worth a combined $1.23B — down 39% from $2.02B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of CDNA and 26 opened new positions — a net loss of 24 holders — while 49 trimmed existing stakes and 79 added.
The largest buyer was State Street, adding an estimated $32.6M. The largest seller was Casdin Capital, exiting entirely with an estimated $42.7M sold.
- 184 institutional investors held CareDx (CDNA) as of Q2 2022, down from 213 in Q1 2022.
- Funds reported $1.23B of CareDx stock for Q2 2022, down 39% quarter-over-quarter.
- 26 funds opened new CareDx positions in Q2 2022 and 50 closed out, a net change of -24 holders.
- The largest CareDx buyer in Q2 2022 was State Street, an estimated $32.6M added.
- The largest CareDx seller in Q2 2022 was Casdin Capital, an estimated $42.7M sold.
Based on aggregated 13F filings for Q2 2022.